Sopan Pharmaceuticals Limited Closing IPO for Foreign Nepalese Immigrants From Today
Summary
Sopan Pharmaceuticals Limited is closing its IPO issue for foreign Nepalese immigrants today with shares oversubscribed 2.87 times. The company manufactures generic and cephalosporin drugs at its Lalitpur facility.
Key Points
- Sopan Pharmaceuticals Limited closes IPO for foreign Nepalese immigrants on 12th Chaitra 2082.
- Total issued capital is Rs. 1.71 Arba with 25% shares offered to the public.
- 10% of the public shares are reserved for Nepalese citizens working abroad, with a minimum of 10 and maximum of 11,000 units per applicant.
- IPO is oversubscribed 2.87 times with 84,324 applicants applying for 12,32,850 units.
